Hong Kong · Delayed Price · Currency is HKD CSPC Pharmaceutical Group Statistics
Total Valuation
HKG:1093 has a market cap or net worth of HKD 106.51 billion. The enterprise value is 88.08 billion.
| Market Cap | 106.51B |
| Enterprise Value | 88.08B |
Important Dates
The next estimated earnings date is Tuesday, November 17, 2026.
| Earnings Date | Nov 17, 2026 |
| Ex-Dividend Date | Oct 20, 2026 |
Share Statistics
HKG:1093 has 11.42 billion shares outstanding. The number of shares has decreased by -1.02% in one year.
| Current Share Class | 11.42B |
| Shares Outstanding | 11.42B |
| Shares Change (YoY) | -1.02% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 26.50% |
| Owned by Institutions (%) | 36.20% |
| Float | 7.63B |
Valuation Ratios
The trailing PE ratio is 12.42 and the forward PE ratio is 12.48. HKG:1093's PEG ratio is 1.70.
| PE Ratio | 12.42 |
| Forward PE | 12.48 |
| PS Ratio | 2.95 |
| PB Ratio | 2.34 |
| P/TBV Ratio | 2.68 |
| P/FCF Ratio | 7.68 |
| P/OCF Ratio | 6.82 |
| PEG Ratio | 1.70 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.64, with an EV/FCF ratio of 6.35.
| EV / Earnings | 10.27 |
| EV / Sales | 2.44 |
| EV / EBITDA | 7.64 |
| EV / EBIT | 8.78 |
| EV / FCF | 6.35 |
Financial Position
The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.14 |
| Quick Ratio | 1.90 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.07 |
| Debt / FCF | 0.05 |
| Interest Coverage | 288.72 |
Financial Efficiency
Return on equity (ROE) is 20.90% and return on invested capital (ROIC) is 31.65%.
| Return on Equity (ROE) | 20.90% |
| Return on Assets (ROA) | 10.70% |
| Return on Invested Capital (ROIC) | 31.65% |
| Return on Capital Employed (ROCE) | 21.00% |
| Weighted Average Cost of Capital (WACC) | 8.40% |
| Revenue Per Employee | 1.94M |
| Profits Per Employee | 460,430 |
| Employee Count | 18,626 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 2.82 |
Taxes
In the past 12 months, HKG:1093 has paid 1.68 billion in taxes.
| Income Tax | 1.68B |
| Effective Tax Rate | 15.80% |
Stock Price Statistics
The stock price has increased by +3.30% in the last 52 weeks. The beta is 0.76, so HKG:1093's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | +3.30% |
| 50-Day Moving Average | 8.98 |
| 200-Day Moving Average | 8.67 |
| Relative Strength Index (RSI) | 55.11 |
| Average Volume (20 Days) | 84,613,317 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1093 had revenue of HKD 36.17 billion and earned 8.58 billion in profits. Earnings per share was 0.75.
| Revenue | 36.17B |
| Gross Profit | 25.99B |
| Operating Income | 10.09B |
| Pretax Income | 10.64B |
| Net Income | 8.58B |
| EBITDA | 11.40B |
| EBIT | 10.09B |
| Earnings Per Share (EPS) | 0.75 |
Balance Sheet
The company has 21.27 billion in cash and 753.28 million in debt, with a net cash position of 20.51 billion or 1.80 per share.
| Cash & Cash Equivalents | 21.27B |
| Total Debt | 753.28M |
| Net Cash | 20.51B |
| Net Cash Per Share | 1.80 |
| Equity (Book Value) | 45.52B |
| Book Value Per Share | 3.81 |
| Working Capital | 18.97B |
Cash Flow
In the last 12 months, operating cash flow was 15.62 billion and capital expenditures -1.76 billion, giving a free cash flow of 13.87 billion.
| Operating Cash Flow | 15.62B |
| Capital Expenditures | -1.76B |
| Depreciation & Amortization | 1.32B |
| Net Borrowing | 109.39M |
| Free Cash Flow | 13.87B |
| FCF Per Share | 1.21 |
Margins
Gross margin is 71.85%, with operating and profit margins of 27.89% and 23.71%.
| Gross Margin | 71.85% |
| Operating Margin | 27.89% |
| Pretax Margin | 29.43% |
| Profit Margin | 23.71% |
| EBITDA Margin | 31.51% |
| EBIT Margin | 27.89% |
| FCF Margin | 37.89% |
Dividends & Yields
This stock pays an annual dividend of 0.36, which amounts to a dividend yield of 3.83%.
| Dividend Per Share | 0.36 |
| Dividend Yield | 3.83% |
| Dividend Growth (YoY) | 37.50% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 43.94% |
| FCF Payout Ratio | 27.17% |
| Buyback Yield | 1.02% |
| Shareholder Yield | 4.86% |
| Earnings Yield | 8.05% |
| FCF Yield | 13.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for HKG:1093 is 12.54, which is 33.55% higher than the current price. The consensus rating is "Buy".
| Price Target | 12.54 |
| Price Target Difference | 33.55% |
| Analyst Consensus | Buy |
| Analyst Count | 24 |
| Revenue Growth Forecast (3Y) | 8.58% |
| EPS Growth Forecast (3Y) | 27.08% |
Stock Splits
The last stock split was on October 15, 2020. It was a forward split with a ratio of 1.6.
| Last Split Date | Oct 15, 2020 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
HKG:1093 has an Altman Z-Score of 5.49 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.49 |
| Piotroski F-Score | 6 |